Soltis Investment Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$925K Buy
1,954
+93
+5% +$46.8K 0.06% 232
2025
Q4
$869K Sell
1,861
-39
-2% -$18.1K 0.06% 229
2025
Q3
$810K Buy
1,900
+11
+0.6% +$4.26K 0.06% 229
2025
Q2
$724K Buy
1,889
+133
+8% +$47.9K 0.06% 210
2025
Q1
$607K Buy
1,756
+75
+4% +$24.1K 0.05% 216
2024
Q4
$504K Buy
1,681
+6
+0.4% +$2.1K 0.05% 238
2024
Q3
$681K Sell
1,675
-247
-13% -$90.4K 0.07% 191
2024
Q2
$618K Buy
+1,922
New +$624K 0.07% 189

Other funds holding HCA

Soltis Investment Advisors's HCA Position: Q1 2026 in Review

Soltis Investment Advisors increased its HCA Healthcare (HCA) stake by 5% in Q1 2026, buying an estimated $46.8K and bringing the position to 1,954 shares worth $925K. The position accounts for 0.06% of the portfolio, ranked #232.

Soltis Investment Advisors first reported a position in HCA in Q2 2024 and has held it in 8 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Soltis Investment Advisors held 1,954 shares of HCA Healthcare worth $925K as of Q1 2026.
  • Soltis Investment Advisors bought 93 HCA Healthcare shares in Q1 2026, an estimated $46.8K.
  • HCA Healthcare made up 0.06% of Soltis Investment Advisors's portfolio in Q1 2026, its #232 holding.
  • Soltis Investment Advisors first reported a position in HCA Healthcare in Q2 2024 and has held it in 8 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.